Sampath‐Kumar Anandan

Inhibition of Soluble Epoxide Hydrolase Attenuated Atherosclerosis, Abdominal Aortic Aneurysm Formation, and Dyslipidemia

Le-Ning Zhang, Jon Vincelette, Ying Cheng et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 115 citations · Full text

Medicine, Cardiology, Pharmacology +15

Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension

Le-Ning Zhang, Jon Vincelette, Dawn Chen et al. · European Journal of Pharmacology · 2010 · 72 citations

Veterinary Medicine, Pharmacology, Physiology +16

1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia

Sampath‐Kumar Anandan, Heather K. Webb, Dawn Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 72 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

N- and C-terminal modifications of negamycin

B. China Raju, Kathleen H. Mortell, Sampath‐Kumar Anandan et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 53 citations

Pharmacy, Medicinal Chemistry, Synthetic Medicinal Chemistry +1

Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors

Sampath‐Kumar Anandan, John S. Ward, Richard D. Brokx et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 35 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +9